ClinicalTrials.Veeva

Menu

How Many Patients Suffering Major Trauma Would be Eligible for a Pre-hospital Transfusion (TRAP)

H

Hôpital NOVO

Status

Not yet enrolling

Conditions

Trauma Injury

Treatments

Other: Data Collection

Study type

Observational

Funder types

Other

Identifiers

NCT06494293
CHRD1024

Details and patient eligibility

About

The aim of the study is to measure the number of patients being cared for by a medical team for major trauma who could benefit from a transfusion labile blood products and thus provide a scientific argument in favour of supplying labile blood products to pre-hospital

Full description

In France, pre-hospital resuscitation of major trauma patients does not use labile blood products, except in exceptional circumstances. The physician staffed Mobile Intensive Care Unit (MICU) are not equipped with this type of product. The first cause of death compatible with survival in the event of pre-hospital treatment identified in major trauma in war medicine is exsanguination. Mortality in haemorrhagic shock occurs rapidly and appears to be significantly reduced if transfusions are performed early. Early transfusion has proved its worth in the military context, leading the armed forces health service to recommend transfusion as a first-line treatment as quickly as possible, from the moment the patient is taken into care on the battlefield. More recently, in the North American civilian pre-hospital setting, the PAMPer study included 501 patients, 230 of whom were transfused with fresh frozen plasma (FFP - 2 units). The authors reported a significant reduction in mortality at D+30 in the FFP group (23.2% vs 33%; p=0.03). It therefore seems that transfusion as early as possible is associated with a reduction in mortality in the context of major trauma.

The aim of the study is to measure the number of patients being cared for by a medical team for major trauma who could benefit from a transfusion labile blood products and thus provide a scientific argument in favour of supplying labile blood products to pre-hospital.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria :

  • Patients over 18
  • Taken care of by a MICU team from participating centres
  • Victims of major trauma requiring transport to an emergency/recovery unit or declared dead during care
  • Informed and did not object to the collection of his data for research purposes during his lifetime

Exclusion Criteria :

  • Traumatological reason for departure not confirmed in the emergency medical services report
  • Patient care of by the MICU for secondary transport (transport from one hospital to another)
  • Patient died without resuscitation by a professional
  • Patient with manifest isolated closed head injury
  • Patient deprived of civil rights

Trial design

200 participants in 1 patient group

Data collection
Description:
Collection of medical data from MICU intervention file and patient medical files from participating centres
Treatment:
Other: Data Collection

Trial contacts and locations

4

Loading...

Central trial contact

Véronique DA COSTA; Maryline DELATTRE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems